Overview
Jeffrey Langsam is a Hematologist Oncology specialist and a Hematologist in New Britain, Connecticut. Dr. Langsam is rated as an Experienced provider by MediFind in the treatment of Non-Langerhans-Cell Histiocytosis. His top areas of expertise are Pleuropulmonary Blastoma, Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), and ALK-Positive Non-Small Cell Lung Cancer.
His clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Non-Langerhans-Cell Histiocytosis.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Mercy Medical Group Inc
Masih Farooqui is a Hematologist Oncology specialist and a Hematologist in Springfield, Massachusetts. Dr. Farooqui is rated as a Distinguished provider by MediFind in the treatment of Non-Langerhans-Cell Histiocytosis. His top areas of expertise are Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, Lung Cancer, and Paget Disease of the Breast.
Yale University
Johanna Lasala is a Hematologist Oncology specialist and a Hematologist in Guilford, Connecticut. Dr. Lasala is rated as a Distinguished provider by MediFind in the treatment of Non-Langerhans-Cell Histiocytosis. Her top areas of expertise are Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Breast Cancer.
Yale University
Prajwal Boddu is a Hematologist Oncology specialist and a Hematologist in New Haven, Connecticut. Dr. Boddu is rated as an Advanced provider by MediFind in the treatment of Non-Langerhans-Cell Histiocytosis. His top areas of expertise are Leukemia, Acute Myeloid Leukemia (AML), Philadelphia-Negative Chronic Myeloid Leukemia, and Chronic Myelogenous Leukemia (CML).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- Lung AdenocarcinomaDr. Langsam isAdvanced. Learn about Lung Adenocarcinoma.
- Pleuropulmonary BlastomaDr. Langsam isAdvanced. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Langsam isAdvanced. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Langsam isAdvanced. Learn about Squamous Cell Lung Carcinoma.
- Experienced
- AgranulocytosisDr. Langsam isExperienced. Learn about Agranulocytosis.
- AnemiaDr. Langsam isExperienced. Learn about Anemia.
- Bone TumorDr. Langsam isExperienced. Learn about Bone Tumor.
- Childhood Iron Deficiency AnemiaDr. Langsam isExperienced. Learn about Childhood Iron Deficiency Anemia.
- ChordomaDr. Langsam isExperienced. Learn about Chordoma.
- Chronic Familial NeutropeniaDr. Langsam isExperienced. Learn about Chronic Familial Neutropenia.